Correlation Between Pmv Pharmaceuticals and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Enliven Therapeutics, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Enliven Therapeutics.
Diversification Opportunities for Pmv Pharmaceuticals and Enliven Therapeutics
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Pmv and Enliven is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Enliven Therapeutics
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 113.83 times less return on investment than Enliven Therapeutics. But when comparing it to its historical volatility, Pmv Pharmaceuticals is 1.59 times less risky than Enliven Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Enliven Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 1,570 in Enliven Therapeutics on August 28, 2024 and sell it today you would earn a total of 918.00 from holding Enliven Therapeutics or generate 58.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Enliven Therapeutics
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Enliven Therapeutics |
Pmv Pharmaceuticals and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Enliven Therapeutics
The main advantage of trading using opposite Pmv Pharmaceuticals and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen |
| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world |